Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Idiopathic pulmonary fibrosis

Recruiting

Investigational

A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:HUMANISED IGG1 LALAPS-YTE MONOCLONAL ANTIBODY AGAINST LYSOPHOSPHATIDIC ACID RECEPTOR 1

Contact Research Centre

Secondary progressive multiple sclerosis

Recruiting

Investigational

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Remibrutinib

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drug

Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Glycogen storage disease type II

Recruiting

Investigational

A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

Investigational

Germany

Participants:18–64 years

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Investigational

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:BLEXIMENIB

Contact Research Centre

Non-small cell lung cancer stage IIIA+2

Recruiting

Registered drugNo placebo

Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Squamous cell carcinoma of skin

Recruiting

InvestigationalNo placebo

A study of onfekafusp alfa and bifikafusp alfa injected into tumors for patients with advanced skin squamous cell cancer who did not respond to or could not tolerate previous treatment

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bifikafusp Alfa

Contact Research Centre

Basal cell carcinoma

Recruiting

InvestigationalNo placebo

Study of bifikafusp alfa and onfekafusp alfa injected into tumors for patients with locally advanced basal cell carcinoma who progressed on or cannot tolerate systemic treatment

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bifikafusp Alfa

Contact Research Centre

Basal cell carcinoma

Recruiting

InvestigationalNo placebo

Testing bifikafusp alfa and onfekafusp alfa injections in patients with locally advanced basal cell carcinoma

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bifikafusp Alfa

Contact Research Centre

Crohn's disease

Recruiting

Investigational

Study of icotrokinra for adults with moderately to severely active Crohn's disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:ICOTROKINRA

Contact Research Centre

Colitis ulcerative

Recruiting

Investigational

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:ICOTROKINRA

Contact Research Centre

Acute lymphocytic leukaemia recurrent+5

Recruiting

InvestigationalNo placebo

A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:AZD3632

Contact Research Centre

Find therapies in clinical trials near you – page 4

335 trials match your criteria

Idiopathic pulmonary fibrosis

A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

Secondary progressive multiple sclerosis

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Acute myeloid leukaemia

Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Glycogen storage disease type II

A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

Acute myeloid leukaemia

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Non-small cell lung cancer stage IIIA+2

Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

Squamous cell carcinoma of skin

A study of onfekafusp alfa and bifikafusp alfa injected into tumors for patients with advanced skin squamous cell cancer who did not respond to or could not tolerate previous treatment

Basal cell carcinoma

Study of bifikafusp alfa and onfekafusp alfa injected into tumors for patients with locally advanced basal cell carcinoma who progressed on or cannot tolerate systemic treatment

Basal cell carcinoma

Testing bifikafusp alfa and onfekafusp alfa injections in patients with locally advanced basal cell carcinoma

Crohn's disease

Study of icotrokinra for adults with moderately to severely active Crohn's disease

Colitis ulcerative

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Acute lymphocytic leukaemia recurrent+5

A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.